Table 6.

Venom immunotherapy protocols with omalizumab.

Patient 1	Patient 2
Systemic reaction with 4. vial 0.8 cc dose of immunotherapy	Systemic reaction with 4. vial 0.6 cc dose of immunotherapy
week 0: 150 mg omalizumab	week 0: 150 mg omalizumab
week 1: 4. vial 0.3 cc	week 2: 4. vial 0.4 cc (with 150 mg omalizumab before 4 h), no reaction
week 2: 4. vial 0.4 cc (with 150 mg omalizumab before 4 h), no reaction	week 3: 4. vial 0.5 cc, no reaction
week 3: 4. vial 0.5 cc, no reaction	week 4: 4. vial 0.6 cc (with 150 mg omalizumab before 4 h), no reaction
week 4: 4. vial 0.6 cc (with 150 mg omalizumab before 4 h), no reaction	week 5: 4. vial 0.7 cc, no reaction
week 5: 4. vial 0.7 cc, systemic reaction with chills, hypotension, cough and dyspnea	week 6: 4. vial 0.8 cc (with 150 mg omalizumab before 4 hours), no reaction
	week 7: 4. vial 0.9 cc, no reaction
	week 8: 4. vial 1 cc (with 150 mg omalizumab before 4 hours), no reaction
	week 10: 4. vial 1 cc, no reaction
	week 13: 4. vial 1 cc, no reaction
	week 17: 4. vial 1 cc, systemic reaction with facial erythema and itching, nausea, uvula edema and dyspnea
	week 19: 4. vial 0.4 cc (with 150 mg omalizumab before 4 h), systemic reaction with uvula edema, dyspnea, facial erythema and itching